1. Davis, E. L. et al. Contact tracing is an imperfect tool for controlling COVID-19 transmission and relies on population adherence. Nat. Commun. 12, (2021).
2. Yalaman, A., Basbug, G., Elgin, C. & Galvani, A. P. Cross-country evidence on the association between contact tracing and COVID-19 case fatality rates. Sci. Rep. 11, (2021).
3. World Health Organization and others. Contact tracing in the context of COVID-19: interim guidance, 10 May 2020. (2020).
4. European Centre for Disease Prevention and Control. Contact tracing: Public health management of persons, including healthcare workers, having had contact with COVID-19 cases in the European Union-second update. ECDC, Stock. (2020).
5. Endo, A. et al. Implication of backward contact tracing in the presence of overdispersed transmission in COVID-19 outbreaks. Wellcome Open Res. 5, (2021).
6. Kojaku, S., Hébert-Dufresne, L., Mones, E., Lehmann, S. & Ahn, Y.-Y. The effectiveness of backward contact tracing in networks. Nat. Phys. 17, (2021).
7. Bradshaw, W. J., Alley, E. C., Huggins, J. H., Lloyd, A. L. & Esvelt, K. M. Bidirectional contact tracing could dramatically improve COVID-19 control. Nat. Commun. 12, (2021).
8. Demirgüç‐Kunt, A., Lokshin, M. & Torre, I. The sooner, the better: The economic impact of non‐pharmaceutical interventions during the early stage of the COVID‐19 pandemic. Econ. Transit. Institutional Chang. 29, (2021).
9. Kretzschmar, M. E. et al. Impact of delays on effectiveness of contact tracing strategies for COVID-19: a modelling study. Lancet Public Heal. 5, (2020).
10. Scarabel, F., Pellis, L., Ogden, N. H. & Wu, J. A renewal equation model to assess roles and limitations of contact tracing for disease outbreak control. R. Soc. Open Sci. 8, (2021).
11. Fyles, M. et al. Using a household-structured branching process to analyse contact tracing in the SARS-CoV-2 pandemic. Philos. Trans. R. Soc. B Biol. Sci. 376, (2021).
12. Karlinsky, A. & Kobak, D. Tracking excess mortality across countries during the COVID-19 pandemic with the World Mortality Dataset. Elife 10, (2021).
13. Ge, Y. et al. COVID-19 Transmission Dynamics Among Close Contacts of Index Patients With COVID-19. JAMA Intern. Med. (2021) doi:10.1001/jamainternmed.2021.4686.
14. Ren, X. et al. Evidence for pre‐symptomatic transmission of coronavirus disease 2019 (COVID‐19) in China. Influenza Other Respi. Viruses 15, (2021).
15. Casey-Bryars, M. et al. Presymptomatic transmission of SARS-CoV-2 infection: a secondary analysis using published data. BMJ Open 11, (2021).
16. Hu, S. et al. Infectivity, susceptibility, and risk factors associated with SARS-CoV-2 transmission under intensive contact tracing in Hunan, China. Nat. Commun. 12, (2021).
17. Adam, D. C. et al. Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong. Nat. Med. 26, (2020).
18. Endo, A., Abbott, S., Kucharski, A. J. & Funk, S. Estimating the overdispersion in COVID-19 transmission using outbreak sizes outside China. Wellcome Open Res. 5, (2020).
19. R, L. et al. Epidemiology and transmission dynamics of COVID-19 in two Indian states. Science 370, (2020).
20. Bi, Q. et al. Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study. Lancet. Infect. Dis. 20, 911–919 (2020).
21. Edwards, D. A. et al. Exhaled aerosol increases with COVID-19 infection, age, and obesity. Proc. Natl. Acad. Sci. 118, (2021).
22. Chen, P. Z. et al. Heterogeneity in transmissibility and shedding SARS-CoV-2 via droplets and aerosols. Elife 10, (2021).
23. Sneppen, K., Nielsen, B. F., Taylor, R. J. & Simonsen, L. Overdispersion in COVID-19 increases the effectiveness of limiting nonrepetitive contacts for transmission control. Proc. Natl. Acad. Sci. 118, (2021).
24. Whaley, C. M., Cantor, J., Pera, M. & Jena, A. B. Assessing the Association Between Social Gatherings and COVID-19 Risk Using Birthdays. JAMA Intern. Med. 181, (2021).
25. Shimizu, K. & Negita, M. Lessons Learned from Japan’s Response to the First Wave of COVID-19: A Content Analysis. Healthcare 8, (2020).
26. Yong, S. E. F. et al. Connecting clusters of COVID-19: an epidemiological and serological investigation. Lancet Infect. Dis. 20, (2020).
27. Finkel, A., Jasper, L. & Weeramanthri, T. National Contact Tracing Review: A report for Australia’s National Cabinet. (2020).
28. Leclerc, Q. J., Fuller, N. M., Knight, L. E., Funk, S. & Knight, G. M. What settings have been linked to SARS-CoV-2 transmission clusters? Wellcome Open Res. 5, (2020).
29. Kasy, M. & Teytelboym, A. Adaptive targeted infectious disease testing. Oxford Rev. Econ. Policy 36, (2020).
30. Pezzutto, M., Bono Rosselló, N., Schenato, L. & Garone, E. Smart testing and selective quarantine for the control of epidemics. Annu. Rev. Control 51, (2021).
31. Wang, C. C. et al. Airborne transmission of respiratory viruses. Science (80-. ). 373, eabd9149 (2021).
32. World Health Orgnisation. Public health criteria to adjust public health and social measures in the context of COVID-19 Annex to Considerations in adjusting public health and social measures in the context of COVID-19. https://apps.who.int/iris/bitstream/handle/10665/332073/WHO-2019-nCoV-Adjusting_PH_measures-Criteria-2020.1-eng.pdf?sequence=1&isAllowed=y (2020).
33. ECDC. Maps in support of the Council Recommendation on a coordinated approach to travel measures in the EU. https://www.ecdc.europa.eu/en/covid-19/situation-updates/weekly-maps-coordinated-restriction-free-movement.
34. Mossong, J. et al. Social Contacts and Mixing Patterns Relevant to the Spread of Infectious Diseases. PLoS Med. 5, (2008).
35. Shah, A. S. V. et al. Effect of Vaccination on Transmission of SARS-CoV-2. N. Engl. J. Med. (2021) doi:10.1056/NEJMc2106757.
36. Ke, R., Martinez, P., Smith, R., Gibson, L. & Achenbach, C. Longitudinal analysis of SARS-CoV-2 vaccine breakthrough infections reveal limited infectious virus shedding and restricted tissue distribution. medRxiv (2021) doi:https://doi.org/10.1101/2021.08.30.21262701.
37. Raymenants, J. et al. Integrated PCR testing and extended window contact tracing system for COVID-19 to improve comprehensiveness and speed.